Biacore's Report January - September, 2001 Brought Forward One Day.Business Editors/Health & Medical Writers UPPSALA, Sweden--(BUSINESS WIRE)--Aug. 29, 2001 Biacore International AB (Biacore) (SSE (1) An earlier full-screen editor in OS/2. (2) (Streaming SIMD Extensions) A series of additional instructions built into Pentium CPU chips for improved multimedia performance by performing mathematical operations on multiple sets of data at the : BCOR.) (Nasdaq: BCOR) today announced a correction as regards the disclosure of the Company's next interim report. Biacore's report for the period January - September 2001 will be published on Thursday, October 18, 2001, a day earlier than originally announced. Notes to Editors: Biacore is a global market leader in Surface Plasmon Resonance The excitation of surface plasmons by light is denoted as a surface plasmon resonance (SPR) for planar surfaces or localized surface plasmon resonance (LSPR) for nanometer-sized metallic structures. (SPR spr Spring SPR Strategic Petroleum Reserve SPR Surface Plasmon Resonance SPR Suomen Punainen Risti SpR Specialist Registrar (UK doctor who supports a consultant) SPR Society for Psychical Research SPR Stop Prisoner Rape ) based technology with its own sales operations in the U.S., across Europe, in Japan, Australia and New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. . The technology is protected by a strong patent portfolio. Target groups consist primarily of medical and life science research laboratories and pharmaceutical and biotechnology companies worldwide. Biacore focuses on drug discovery as the prime area for future growth. The Company currently has seven systems on the market with its BiacoreS51(R) for applications downstream of high-throughput screening (HTS HTS Heights HTS Harmonized Tariff System HTS High Throughput Screening (biomolecular assay screening) HTS High-Throughput Screening (Pharmaceutical Industry) HTS Harmonized Tariff Schedule ) including rapid characterization of HTS hits and comprehensive preclinical evaluation of lead compounds. Biacore(R)3000 offers specific applications in drug discovery upstream of HTS. A new SPR array system is currently under development. Based in Uppsala, Sweden, the Company is listed on Stockholmsborsen and Nasdaq in the U.S. In 2000 the Company had sales of SEK SEK In currencies, this is the abbreviation for the Swedish Krona. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 438.8 million and an operating income of SEK 78.0 million. Further information on Biacore can be found on the web: www.biacore.com Address and phone: Biacore International AB Rapsgatan 7, SE-754 50 Uppsala, SWEDEN Phone: +46 (0)18-675700 Fax: +46 (0)18-150111 info@biacore.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion